Follow this preprint
Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Review of the Research Literature and Published Case Studies
View ORCID ProfileDavid E. Gard, Mollie M. Pleet, Ellen R. Bradley, Andrew Penn, Matthew L. Gallenstein, Lauren S. Riley, Meghan DellaCrosse, Emily Garfinkle, Erin E. Michalak, Joshua D. Woolley
doi: https://doi.org/10.1101/2021.04.02.21254838
Now published in Journal of Affective Disorders Reports doi: 10.1016/j.jadr.2021.100240
David E. Gard
1San Francisco State University, San Francisco, CA USA
Mollie M. Pleet
2University of California San Francisco, San Francisco, CA USA
3San Francisco Veteran’s Affairs Medical Center, San Francisco, CA USA
Ellen R. Bradley
2University of California San Francisco, San Francisco, CA USA
3San Francisco Veteran’s Affairs Medical Center, San Francisco, CA USA
Andrew Penn
2University of California San Francisco, San Francisco, CA USA
Matthew L. Gallenstein
1San Francisco State University, San Francisco, CA USA
Lauren S. Riley
1San Francisco State University, San Francisco, CA USA
Meghan DellaCrosse
4The Wright Institute, Berkeley, CA USA
Emily Garfinkle
5Palo Alto University-Pacific Graduate School of Psychology, Palo Alto, CA USA
Erin E. Michalak
6University of British Columbia, Vancouver, BC Canada
Joshua D. Woolley
2University of California San Francisco, San Francisco, CA USA
3San Francisco Veteran’s Affairs Medical Center, San Francisco, CA USA
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Not applicable
Posted April 17, 2021.
Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Review of the Research Literature and Published Case Studies
David E. Gard, Mollie M. Pleet, Ellen R. Bradley, Andrew Penn, Matthew L. Gallenstein, Lauren S. Riley, Meghan DellaCrosse, Emily Garfinkle, Erin E. Michalak, Joshua D. Woolley
medRxiv 2021.04.02.21254838; doi: https://doi.org/10.1101/2021.04.02.21254838
Now published in Journal of Affective Disorders Reports doi: 10.1016/j.jadr.2021.100240
Subject Area
Subject Areas
- Addiction Medicine (407)
- Allergy and Immunology (718)
- Anesthesia (213)
- Cardiovascular Medicine (3030)
- Dermatology (256)
- Emergency Medicine (453)
- Epidemiology (12949)
- Forensic Medicine (12)
- Gastroenterology (845)
- Genetic and Genomic Medicine (4755)
- Geriatric Medicine (439)
- Health Economics (745)
- Health Informatics (3020)
- Health Policy (1091)
- Hematology (405)
- HIV/AIDS (950)
- Medical Education (448)
- Medical Ethics (118)
- Nephrology (488)
- Neurology (4532)
- Nursing (241)
- Nutrition (669)
- Oncology (2353)
- Ophthalmology (665)
- Orthopedics (262)
- Otolaryngology (332)
- Pain Medicine (294)
- Palliative Medicine (85)
- Pathology (511)
- Pediatrics (1226)
- Primary Care Research (513)
- Public and Global Health (7118)
- Radiology and Imaging (1579)
- Respiratory Medicine (939)
- Rheumatology (456)
- Sports Medicine (396)
- Surgery (502)
- Toxicology (63)
- Transplantation (217)
- Urology (187)